| Literature DB >> 34712605 |
Yaoyao Zhuo1,2, Yi Zhan1, Zhiyong Zhang1,3,4, Fei Shan1,3, Jie Shen1, Daoming Wang5, Mingfeng Yu6.
Abstract
AIM: To investigate clinical and computed tomography (CT) radiomics nomogram for preoperative differentiation of lung adenocarcinoma (LAC) from lung tuberculoma (LTB) in patients with pulmonary solitary solid nodule (PSSN).Entities:
Keywords: CT features; lung adenocarcinoma; nomogram; radiomics; tuberculoma
Year: 2021 PMID: 34712605 PMCID: PMC8546326 DOI: 10.3389/fonc.2021.701598
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Some CT morphological characteristics of pulmonary solitary solid nodule. (A, B) A 30-year-old male, lung tuberculoma (LTB) with spiculated sign (arrow). (C, D) A 65-year-old female, LTB with air bronchogram (arrow). (E, F) A 62-year-old female, lung adenocarcinoma (LAC) with lobulated sign (arrow). (G, H) A 33-year-old female, LAC with air bronchogram and pleural indentation (arrow).
Figure 2Overview of the study methodology.
The clinical and CT image characteristics of participants.
| All patients (n = 313) | Adenocarcinoma (n = 96) | Tuberculoma (n = 217) | p-value | |
|---|---|---|---|---|
| Age (years) | 49.76 ± 18.16 | 59.43 ± 11.49 | 45.49 ± 18.93 | <0.001 |
| Gender | <0.001 | |||
| Female | 108 (34.50)* | 52 (54.17) | 56 (25.81) | |
| Male | 205 (65.50) | 44 (45.83) | 161 (74.19) | |
| Maximum diameter of nodule (mm) | 15.66 ± 5.27 | 18.05 ± 6.06 | 14.61 ± 4.50 | <0.001 |
| Minimum diameter of nodule (mm) | 11.92 ± 4.11 | 13.95 ± 4.82 | 11.01 ± 3.40 | <0.001 |
| Mean diameter of nodule (mm) | 13.79 ± 4.50 | 15.99 ± 5.24 | 12.81 ± 3.75 | <0.001 |
| Spiculated sign | <0.001 | |||
| Present | 227 (72.52) | 83 (86.46) | 144 (66.36) | |
| Absent | 86 (27.48) | 13 (13.54) | 73 (33.64) | |
| Cavity | 0.255 | |||
| Present | 32 (10.22) | 7 (7.29) | 25 (11.52) | |
| Absent | 281 (89.78) | 89 (92.71) | 192 (88.48) | |
| Vacuole | 0.015 | |||
| Present | 20 (6.39) | 11 (11.46) | 9 (4.15) | |
| Absent | 293 (93.61) | 85 (88.54) | 208 (95.85) | |
| Boundary | <0.001 | |||
| Clear | 306 (97.76) | 89 (92.71) | 217 (100.00) | |
| Unclear | 7 (2.24) | 7 (7.29) | 0 (0.00) | |
| Lobulated sign | <0.001 | |||
| Present | 196 (62.62) | 95 (98.96) | 101 (46.54) | |
| Absent | 117 (37.38) | 1 (1.04) | 116 (53.46) | |
| Air bronchogram | 0.031 | |||
| Present | 177 (62.26) | 63 (51.43) | 114 (52.53) | |
| Absent | 136 (37.74) | 33 (48.57) | 103 (47.47) | |
| Pleural indentation | 0.287 | |||
| Present | 234 (74.76) | 68 (70.83) | 166 (76.50) | |
| Absent | 79 (25.24) | 28 (29.17) | 51 (23.50) | |
| Pulmonary vascular abnormalities | 0.065 | |||
| Present | 270 (86.26) | 88 (91.77) | 182 (83.87) | |
| Absent | 43 (13.74) | 8 (8.33) | 35 (16.13) | |
| Mediastinal lymphadenectasis | <0.001 | |||
| Present | 105 (33.55) | 16 (16.67) | 89 (41.01) | |
| Absent | 208 (66.45) | 80 (83.33) | 128 (58.99) |
*Data are numbers of patients, with percentages in parentheses.
Figure 3Radiomics features selection. The least absolute shrinkage and selection operator included (A) choosing the regular parameter λ and (B) determining the number of the feature. A total of 15 radiomics features were chosen (C).
Figure 4Construction, performance, and validation of radiomics nomogram. (A) The radiomics nomogram was developed using seven selected radiomics parameters and two clinical features. Receiver operating characteristic (ROC) curves of nomogram and clinical model in training set (B) and validation set (C).
The clinical model, radiomics signature, and radiomics nomogram for patients with LAC and LTB in training and validation sets.
| Group | Model | AUC curve (95% CI) | Accuracy | Sensitivity | Specificity | PPV | NPV |
|---|---|---|---|---|---|---|---|
| Training set | Clinical model | 0.92 (0.88–0.95) | 0.8500 | 0.9612 | 0.6923 | 0.8158 | 0.9265 |
| Radiomics signature | 0.99 (0.98–1.00) | 0.9727 | 0.9706 | 0.9737 | 0.9429 | 0.9867 | |
| Radiomics nomogram | 1.00 (0.98–1.00) | 0.9772 | 0.9868 | 0.9565 | 0.9803 | 0.9706 | |
| Validation set | Clinical model | 0.91 (0.86–0.97) | 0.7849 | 0.9245 | 0.6000 | 0.7538 | 0.8571 |
| Radiomics signature | 0.99 (0.98–1.00) | 0.9462 | 0.9643 | 0.9385 | 0.8710 | 0.9839 | |
| Radiomics nomogram | 0.99 (0.98–1.00) | 0.9570 | 0.9841 | 0.9000 | 0.9538 | 0.9643 |
AUC curve, the area under receiver operating characteristic curve; CI, confidence interval; LAC, lung adenocarcinoma; LTB, lung tuberculoma; PPV, positive predictive value; NPV, negative predictive value.
Figure 5Validation of radiomics nomogram, the calibration curves of radiomics nomogram in training set (A) and validation set (B). Decision curve analysis for radiomics and clinical model to evaluate the clinical usefulness of the model (C).